Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects.
Article Details
- CitationCopy to clipboard
Chin PK, Jensen BP, Larsen HS, Begg EJ
Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects.
Br J Clin Pharmacol. 2011 Dec;72(6):985-9. doi: 10.1111/j.1365-2125.2011.04036.x.
- PubMed ID
- 21671987 [ View in PubMed]
- Abstract
AIM: To see if adult age correlates with ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. METHODS: Sixty healthy drug free subjects were recruited in the age groups 18-39, 40-64 and >/=65 years. Plasma albumin concentrations were determined. Ex vivo unbound fractions (f(u)) were assessed by spiking samples and measuring the free and total concentrations. RESULTS: No correlation of age with f(u) was seen. The study was powered to demonstrate a change in f(u) of >/=7-10%. A decline in plasma albumin concentration of ~0.03 g l(-1) year(-1) was seen with increasing age (P= 0.032) and was associated with increased f(u) of lorazepam (P= 0.009) and oxazepam (P= 0.014). CONCLUSIONS: There was no association of adult age with ex vivo f(u) of lorazepam, oxazepam or temazepam in healthy subjects.
DrugBank Data that Cites this Article
- Drugs
- Drug Carriers
Drug Carrier Kind Organism Pharmacological Action Actions Oxazepam Serum albumin Protein Humans UnknownBinderDetails